Cargando…
Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment
BACKGROUND: There is limited information on innate immunity, especially natural killer (NK) cell function, in different chronic hepatitis B (CHB) stages. Therefore, we examined whether the clinical staging strategy accurately reflects veritable NK cell immunity. METHODS: A total of 237 eligible CHB...
Autores principales: | Li, Xiaoyan, Zhou, Liang, Gu, Lin, Gu, Yurong, Chen, Lubiao, Lian, Yifan, Huang, Yuehua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663047/ https://www.ncbi.nlm.nih.gov/pubmed/29089040 http://dx.doi.org/10.1186/s12967-017-1318-1 |
Ejemplares similares
-
Serum HBV pregenomic RNA is correlated with Th1/Th2 immunity in treatment‐naïve chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019) -
An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B
por: Gu, Yurong, et al.
Publicado: (2020) -
A Practical Model Evaluating Antiviral Cytokines by Natural Killer Cells in Treatment Naïve Patients with Chronic Hepatitis B Virus Infection
por: Li, Xiaoyan, et al.
Publicado: (2017) -
HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression
por: Chen, Lubiao, et al.
Publicado: (2016) -
Correlations between cytokines produced by T cells and clinical-virological characteristics in untreated chronic hepatitis B patients
por: Gu, Yurong, et al.
Publicado: (2019)